Cite
HARVARD Citation
Wolf, D. et al. (2014). Escalation to weekly dosing recaptures response in adalimumab‐treated patients with moderately to severely active ulcerative colitis. Alimentary pharmacology & therapeutics. 40 (5), pp. 486-497. [Online].